目的 探讨血清巨噬细胞移动抑制因子(MIF)对严重脓毒症患者心肌抑制的预后价值.方法 采用前瞻性研究方法,对符合严重脓毒症诊断标准的42例患者进行研究,入住ICU当天知情同意后行PICCO监测,并给予相应治疗.入住当天根据血流动力学分为两组,心脏指数<3 L/(min·m2)并且全心舒张末期容积指数>800 ml/m2为心肌抑制组,其余为非心肌抑制组.根据28 d生存情况分为生存组和死亡组.入住第1,3,5天收集血流动力学指标及血清MIF、B型钠尿肽(BNP)、心肌肌钙蛋白I(cTnI)水平.结果 42例严重脓毒症患者中,未发生心肌抑制22例(非心肌抑制组),发生心肌抑制20例(心肌抑制组);28 d时,生存20例(生存组),死亡22例(死亡组).死亡组第1,3,5天血清MIF均高于生存组,差异有统计学意义(P<0.01);两组第1天BNP、cTnI比较差异无统计学意义(P>0.05),死亡组第3,5天BNP、cTnI均高于生存组,差异有统计学意义(P<0.01).心肌抑制组各时间点血清MIF水平均明显高于非心肌抑制组[生存:8.70(3.53,16.80) μg/L比1.20(0.80,1.77) μg/L、2.30(1.33,8.40) μg/L比0.60(0.60,0.99) μg/L、0.50(0.31,2.50) μg/L比0.16(0.15,0.20) μg/L,死亡:11.43(8.10,17.16)μg/L比2.30(1.96,3.69) μg/L、9.70(6.55,14.65)μg/L比1.90(1.88,5.27) μg/L、7.50(5.15,14.20) μg/L比2.40(0.80,8.46) μg/L],差异有统计学意义(P<0.05);且两组死亡患者血清MIF水平均高于生存患者,差异有统计学意义(P<0.05).第5天MIF具有最大预测价值,曲线下面积为0.952,当其截断点为0.65 μg/L时,其灵敏度为100%(22/22),特异度为85%(17/20).多因素Logistic回归分析结果显示,仅APACHEⅡ评分是28 d病死率的独立危险因素(P<0.01),而MIF不能独立预测28d病死率(P>0.05).结论 血清MIF水平升高提示严重脓毒症患者预后差,动态监测血清MIF变化有助于评估严重脓毒症患者心肌抑制的预后和严重程度,但MIF不是预测28 d病死率的独立危险因素.
目的 探討血清巨噬細胞移動抑製因子(MIF)對嚴重膿毒癥患者心肌抑製的預後價值.方法 採用前瞻性研究方法,對符閤嚴重膿毒癥診斷標準的42例患者進行研究,入住ICU噹天知情同意後行PICCO鑑測,併給予相應治療.入住噹天根據血流動力學分為兩組,心髒指數<3 L/(min·m2)併且全心舒張末期容積指數>800 ml/m2為心肌抑製組,其餘為非心肌抑製組.根據28 d生存情況分為生存組和死亡組.入住第1,3,5天收集血流動力學指標及血清MIF、B型鈉尿肽(BNP)、心肌肌鈣蛋白I(cTnI)水平.結果 42例嚴重膿毒癥患者中,未髮生心肌抑製22例(非心肌抑製組),髮生心肌抑製20例(心肌抑製組);28 d時,生存20例(生存組),死亡22例(死亡組).死亡組第1,3,5天血清MIF均高于生存組,差異有統計學意義(P<0.01);兩組第1天BNP、cTnI比較差異無統計學意義(P>0.05),死亡組第3,5天BNP、cTnI均高于生存組,差異有統計學意義(P<0.01).心肌抑製組各時間點血清MIF水平均明顯高于非心肌抑製組[生存:8.70(3.53,16.80) μg/L比1.20(0.80,1.77) μg/L、2.30(1.33,8.40) μg/L比0.60(0.60,0.99) μg/L、0.50(0.31,2.50) μg/L比0.16(0.15,0.20) μg/L,死亡:11.43(8.10,17.16)μg/L比2.30(1.96,3.69) μg/L、9.70(6.55,14.65)μg/L比1.90(1.88,5.27) μg/L、7.50(5.15,14.20) μg/L比2.40(0.80,8.46) μg/L],差異有統計學意義(P<0.05);且兩組死亡患者血清MIF水平均高于生存患者,差異有統計學意義(P<0.05).第5天MIF具有最大預測價值,麯線下麵積為0.952,噹其截斷點為0.65 μg/L時,其靈敏度為100%(22/22),特異度為85%(17/20).多因素Logistic迴歸分析結果顯示,僅APACHEⅡ評分是28 d病死率的獨立危險因素(P<0.01),而MIF不能獨立預測28d病死率(P>0.05).結論 血清MIF水平升高提示嚴重膿毒癥患者預後差,動態鑑測血清MIF變化有助于評估嚴重膿毒癥患者心肌抑製的預後和嚴重程度,但MIF不是預測28 d病死率的獨立危險因素.
목적 탐토혈청거서세포이동억제인자(MIF)대엄중농독증환자심기억제적예후개치.방법 채용전첨성연구방법,대부합엄중농독증진단표준적42례환자진행연구,입주ICU당천지정동의후행PICCO감측,병급여상응치료.입주당천근거혈류동역학분위량조,심장지수<3 L/(min·m2)병차전심서장말기용적지수>800 ml/m2위심기억제조,기여위비심기억제조.근거28 d생존정황분위생존조화사망조.입주제1,3,5천수집혈류동역학지표급혈청MIF、B형납뇨태(BNP)、심기기개단백I(cTnI)수평.결과 42례엄중농독증환자중,미발생심기억제22례(비심기억제조),발생심기억제20례(심기억제조);28 d시,생존20례(생존조),사망22례(사망조).사망조제1,3,5천혈청MIF균고우생존조,차이유통계학의의(P<0.01);량조제1천BNP、cTnI비교차이무통계학의의(P>0.05),사망조제3,5천BNP、cTnI균고우생존조,차이유통계학의의(P<0.01).심기억제조각시간점혈청MIF수평균명현고우비심기억제조[생존:8.70(3.53,16.80) μg/L비1.20(0.80,1.77) μg/L、2.30(1.33,8.40) μg/L비0.60(0.60,0.99) μg/L、0.50(0.31,2.50) μg/L비0.16(0.15,0.20) μg/L,사망:11.43(8.10,17.16)μg/L비2.30(1.96,3.69) μg/L、9.70(6.55,14.65)μg/L비1.90(1.88,5.27) μg/L、7.50(5.15,14.20) μg/L비2.40(0.80,8.46) μg/L],차이유통계학의의(P<0.05);차량조사망환자혈청MIF수평균고우생존환자,차이유통계학의의(P<0.05).제5천MIF구유최대예측개치,곡선하면적위0.952,당기절단점위0.65 μg/L시,기령민도위100%(22/22),특이도위85%(17/20).다인소Logistic회귀분석결과현시,부APACHEⅡ평분시28 d병사솔적독립위험인소(P<0.01),이MIF불능독립예측28d병사솔(P>0.05).결론 혈청MIF수평승고제시엄중농독증환자예후차,동태감측혈청MIF변화유조우평고엄중농독증환자심기억제적예후화엄중정도,단MIF불시예측28 d병사솔적독립위험인소.
Objective To evaluate the predictive value of serum macrophage migration inhibitory factor (MIF) for myocardial depression in severe sepsis patients.Methods Taken prospective study method,42 cases of severe sepsis patients were enrolled from December 2011 to June 2013.The patients were monitored by PICCO system after informing consent into ICU day,and given the corresponding treatment.According to the hemodynamic parameters were divided into two groups,myocardial depression group:cardiac index < 3 L/(min· m2) and global end diastolic volume index > 800 ml/m2,the remaining were in non myocardial depression group,and the patients were divided into survival group and death group according to 28-d mortality.Hemodynamic parameters and serum MIF,B-type natriuretic peptide (BNP),cardiac troponin Ⅰ (cTnI) level at the 1st,3rd,Sth day after admission.Results Fortty-two severe sepsis patients,non myocardial depression in 22 cases (non myocardial depression group),myocardial suppression in 20 cases (myocardial depression group).At 28 d,20 patients of survival (survival group),22 patients of death (death group).The serum MIF in death group was higher than that in survival group at the 1st,3rd,5th day (P < 0.01) ; BNP and cTnI at the 1st day in two groups had no statistical significance (P >0.05),BNP and cTnI at the 3rd,5th day in death group was higher than that in survival group(P < 0.01).The serum MIF at each time point in myocardial depression group was higher than that in non myocardial depression group [survival:8.70(3.53,16.80) μ g/L vs.1.20(0.80,1.77) μ g/L,2.30(1.33,8.40) μ g/L vs.0.60 (0.60,0.99) μg/L,0.50 (0.31,2.50) μg/Lvs.0.16 (0.15,0.20) μg/L;death:11.43(8.10,17.16) μ g/L vs.2.30(1.96,3.69) μ g/L,9.70(6.55,14.65) μ g/L vs.1.90(1.88,5.27) μ g/L,7.50(5.15,14.20)μ g/L vs.2.40(0.80,8.46) μ g/L] (P < 0.05).The serum MIF of death patients in two groups was higher than that of survival patients (P < 0.05).MIF at the 5th day had biggest prediction value,AUC was 0.952,when the cut-off point of 0.65 μg/L,the sensitivity was 100% (22/22) and specificity was 85% (17/20).Multivariable Logistic regression analysis results showed that only APACHE Ⅱ scores was the independent risk factor for 28-d mortality (P < 0.01),while MIF couldn' t independent forecast 28-d mortality (P > 0.05).Conclusions Elevation of serum MIF prompts severe sepsis patient with poor outcome,and dynamic changes of MIF is helpful to evaluate the prognosis and severity of severe sepsis patients with myocardial depression,but MIF is not an independent risk factor for predicting 28-d mortality.